Rare diseases
Investigational molecules
Locations
100 Dundas Street Suite 200, N6A 5B6
Alimentiv Inc. concentrates on advancing therapeutic strategies for inflammatory bowel diseases, with particular emphasis on ulcerative colitis and Crohn's disease. The organisation investigates optimal treatment targets in patients experiencing moderate to severe disease activity, exploring comprehensive approaches that extend beyond traditional symptomatic control.
The research portfolio addresses the clinical challenge of determining the most effective therapeutic endpoints, comparing conventional symptomatic remission targets against more rigorous multi-dimensional treatment goals that incorporate tissue healing and biological markers.
Alimentiv Inc. runs clinical trials in conditions such as Crohn's disease, Colitis ulcerative, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
